Robert Iannone - 05 Jun 2021 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Role
EVP R&D, Chief Medical Officer
Signature
By: /s/Adam Guttmann, as attorney in fact For: Robert Iannone
Issuer symbol
JAZZ
Transactions as of
05 Jun 2021
Net transactions value
-$212,823
Form type
4
Filing time
09 Jun 2021, 18:57:13 UTC
Next filing
21 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Tax liability $212,823 -1,206 -4% $176.47 29,086 05 Jun 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.
F2 Includes 147 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 28, 2021.